Hunter C Smith Insider Trading
Get free email notifications about insider trading for Hunter C Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hunter C Smith. Hunter C Smith is a Director in GENESEE & WYOMING INC ($GWR) and a CFO and Interim CEO in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a CFO and Treasurer in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a Chief Financial Officer in RHYTHM PHARMACEUTICALS, INC. ($RYTM).
Address: C/O GENESEE & WYOMING INC. 20 WEST AVENUE DARIEN 06820 CT
Companies in which Hunter C Smith is an Insider
GENESEE & WYOMING INC
Trading Symbol: GWRIndustry: RAILROADS, LINE-HAUL OPERATING [4011]
Position of Hunter C Smith: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 30 2019
$GWR Market Capitalization: $4.25B
$GWR Previous Close: $73.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RHYTHM PHARMACEUTICALS, INC.
Trading Symbol: RYTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hunter C Smith: CFO and Interim CEO, Chief Financial Officer, CFO and Treasurer
Holdings: 38,650 shares
Latest Transaction: Apr 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Hunter C Smith
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 23 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 5,000 | 34,400 | 163,094 | |
Apr 23 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 5,000 | 34,400 | 38,650 | 33.7 K to 38.7 K (+14.86 %) |
Jan 20 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 4,000 | 27,520 | 168,094 | |
Jan 20 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 4,000 | 27,520 | 33,650 | 29.7 K to 33.7 K (+13.49 %) |
Jul 21 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | A | 22.53 | 25,000 | 563,250 | 25,000 | |
Mar 31 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | CFO and Interim CEO | Option Exercise | M | 6.88 | 3,900 | 26,832 | 172,094 | |
Mar 31 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | CFO and Interim CEO | Buy | M | 6.88 | 3,900 | 26,832 | 29,650 | 25.8 K to 29.7 K (+15.15 %) |